CAS 116122-36-2|Breviscapin

Introduction：Basic information about CAS 116122-36-2|Breviscapin, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.

Table of Contents

1. Names
2. Breviscapin BiologicalActivity
3. Chemical & Physical Properties
4. Toxicological Information
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
5. Synonyms

Common Name	Breviscapin
CAS Number	116122-36-2	Molecular Weight	1293.34
Density	1.81g/cm3	Boiling Point	891.6ºC at 760mmHg
Molecular Formula	C₅₄H₈₄N₁₆O₂₁	Melting Point	/
MSDS	/	Flash Point	314.9ºC

Names

Name	(2S,3S,4S,5R,6S)-6-[5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
Synonym	More Synonyms

Breviscapin BiologicalActivity

Description	Breviscapine is a crude flavonoid extract of Breviscapine, which is more than 85% of the active ingredient, Breviscapine. Breviscapine has a wide range of cardiovascular pharmacological activities, such as increasing blood flow, improving microcirculation, dilating blood vessels, reducing blood viscosity, promoting fibrinolysis, inhibiting platelet aggregation and thrombosis. Breviscapine has been used in the study of cerebral infarction and its sequelae, cerebral thrombosis, coronary heart disease and angina pectoris[1][2].
Related Catalog	Research Areas >>Cardiovascular DiseaseSignaling Pathways >>Others >>Others
References	[1]. Gao J, et al. Therapeutic Effects of Breviscapine in Cardiovascular Diseases: A Review. Front Pharmacol. 2017 May 23;8:289. [2]. Wen L, et al. Breviscapine: A Review on its Phytochemistry, Pharmacokinetics and Therapeutic Effects. Am J Chin Med. 2021;49(6):1369-1397.

Description

Breviscapine is a crude flavonoid extract of Breviscapine, which is more than 85% of the active ingredient, Breviscapine. Breviscapine has a wide range of cardiovascular pharmacological activities, such as increasing blood flow, improving microcirculation, dilating blood vessels, reducing blood viscosity, promoting fibrinolysis, inhibiting platelet aggregation and thrombosis. Breviscapine has been used in the study of cerebral infarction and its sequelae, cerebral thrombosis, coronary heart disease and angina pectoris[1][2].

Related Catalog

Research Areas >>Cardiovascular DiseaseSignaling Pathways >>Others >>Others

References

[1]. Gao J, et al. Therapeutic Effects of Breviscapine in Cardiovascular Diseases: A Review. Front Pharmacol. 2017 May 23;8:289.

[2]. Wen L, et al. Breviscapine: A Review on its Phytochemistry, Pharmacokinetics and Therapeutic Effects. Am J Chin Med. 2021;49(6):1369-1397.

Chemical & Physical Properties

Density	1.81g/cm3
Boiling Point	891.6ºC at 760mmHg
Molecular Formula	C₅₄H₈₄N₁₆O₂₁
Molecular Weight	1293.34
Flash Point	314.9ºC
Exact Mass	908.164734
PSA	394.47000
Vapour Pressure	3.91E-34mmHg at 25°C
Index of Refraction	1.763
InChIKey	DJSISFGPUUYILV-UHFFFAOYSA-N
SMILES	O=C(O)C1OC(Oc2cc3oc(-c4ccc(O)cc4)cc(=O)c3c(O)c2O)C(O)C(O)C1O
Storage condition	2-8°C

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :: EE4750000

CHEMICAL NAME :: Breviscapine

CAS REGISTRY NUMBER :: 116122-36-2

LAST UPDATED :: 199503

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intravenous

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 1314 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: CTYAD8 Zhongcaoyao. Chinese Traditional and Herbal Medicine. (China International Book Trading Corp., POB 2820, Beijing, Peop. Rep. China) V.11- 1980- Volume(issue)/page/year: 14,33,1983

Synonyms

Scutellarein-7beta-D-glucuronoside

Breviscapine

4H-1-Benzopyran-4-one, 7-(β-D-glucopyranuronosyloxy)-5,6-dihydroxy-2-(4-hydroxyphenyl)-, compd. with 7-[(5ξ)-β-D-xylo-hexopyranuronosyloxy]-5-hydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one ( 1:1)

Scutellarein-7-glucuronide

5,6-Dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-7-yl β-D-glucopyranosiduronic acid - 5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-7-yl (5ξ)-β-D-xylo-hexopyranosiduronic acid (1:1)

Breviscapin

5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4h-chromen-7-yl |A-d-glucopyranosiduronic acid

Scutellarein-7beta-D-glucuronide

Recommended......